- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05961540
Study on the Construction and Application of Breastfeeding Behavior Intervention Program for Mothers of Infants With Congenital Heart Disease
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201102
- Children's Hospital of Fudan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- For infants
CHD was diagnosed within 14 days of birth.
From birth to 14 days old.
Exclusive breastfeeding or mixed feeding during enrollment.
- For mothers
The mother is the primary caretaker for the infant with CHD.
The mother has a smartphone and has the skills to use it.
She has good reading and communication skills and can work fully with others.
In good physical health with no clear disability, such as severe cardiovascular disease, etc.
In good mental health, without any clearly diagnosed anxiety disorders, depression, etc.
Mothers must be at least 18 years old.
Exclusion Criteria:
- For infants
Congenital anomalies such as gastrointestinal anomalies, facial anomalies, cleft lip and palate, and various syndromes due to chromosomal abnormalities are combined.
Cardiac surgery was performed within 14 days of birth.
The infant is not breastfed according to medical standards (for example, with galactosemia, phenylketonuria, or maple glycosuria).
- For mothers
Mothers with mental illness, cognitive impairment, etc. who struggle to communicate effectively.
Those who have contraindications to breastfeeding, such as long-term use of specific types of drugs such as chemotherapy drugs, opioids, anti-epileptic drugs, anti-depressants, psychotropic drugs, etc.
Systemic infectious diseases during feeding include HIV positive, active or untreated tuberculosis, recent syphilis infection, etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Conventional care group
The management of infants with CHD and their mothers is based on the current breastfeeding process and care protocols at the Cardiovascular Centre of the Children's Hospital of Fudan University.
|
|
|
Experimental: Breastfeeding intervention program
Implement intervention programs to improve breastfeeding behaviour among mothers of infants with CHD and observe ongoing changes.
|
Based on the Behavioural Change Wheel theory,the intervention program is developed and implemented to promote the change in breastfeeding behavior of mothers with CHD infants,so as to improve the exclusive breastfeeding rate of this population.Specific programs include:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exclusive breastfeeding rate
Time Frame: At the age of 1month
|
The exclusive breastfeeding rate equals (the number of CHD infants who choose exclusive breastfeeding) divided by (the total number of CHD infants) multiplied by 100%.
|
At the age of 1month
|
|
Exclusive breastfeeding rate
Time Frame: At the age of 3 months
|
The exclusive breastfeeding rate equals (the number of CHD infants who choose exclusive breastfeeding) divided by (the total number of CHD infants) multiplied by 100%.
|
At the age of 3 months
|
|
Exclusive breastfeeding rate
Time Frame: At the age of 6 months
|
The exclusive breastfeeding rate equals (the number of CHD infants who choose exclusive breastfeeding) divided by (the total number of CHD infants) multiplied by 100%.
|
At the age of 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breastfeeding Behavior Questionnaire for Mothers of Infants with CHD
Time Frame: At baseline and at 6 months of age.
|
This questionnaire was created by us with a total of 21 items, which include five dimensions of breastfeeding behavior of mothers of CHD infants: mothers' attention to breastfeeding of children with congenital heart disease, identification of signals of hunger and satiety of infants, breastfeeding skills, methods to promote lactation, and identification and treatment of choking milk during breastfeeding of CHD infants.
The questionnaire uses the Likert5-level scoring method, with a score of 0-105.
The higher the score, the better the breastfeeding behavior of CHD infant mothers.
|
At baseline and at 6 months of age.
|
|
ΔWAZ at 1 month of age compared to birth, separated into two groups.
Time Frame: At the age of 1month
|
The infant's family has created their own digital scale that is as precise as the one used in the hospital.
The weight measurement is accurate to 0.01 kilograms.
For accurate measurement, it is recommended to weigh the baby at the age of one month in the early morning.
Before measuring, the baby scale should be reset to zero, and the baby should be undressed in clothes and diapers.
The baby's weight will be converted to WAZ.
The WAZ at the age of 1 month minus the WAZ converted from birth weight is the ΔWAZ at the age of 1 month after birth.
|
At the age of 1month
|
|
ΔWAZ at 3 months of age compared to birth, separated into two groups.
Time Frame: At the age of 3 months
|
The infant's family has created their own digital scale that is as precise as the one used in the hospital.
The weight measurement is accurate to 0.01 kilograms.
For accurate measurement, it is recommended to weigh the baby at 3 months of age in the early morning.
Before measuring, the baby scale should be reset to zero, and the baby should be undressed in clothes and diapers.
The baby's weight will be converted to WAZ.
The WAZ at the age of 3 months minus the WAZ converted from birth weight is the ΔWAZ at the age of 3 months after birth.
|
At the age of 3 months
|
|
ΔWAZ at 6 months of age compared to birth, separated into two groups.
Time Frame: At the age of 6 months
|
The infant's family has created their own digital scale that is as precise as the one used in the hospital.
The weight measurement is accurate to 0.01 kilograms.
For accurate measurement, it is recommended to weigh the baby at 6 months of age in the early morning.
Before measuring, the baby scale should be reset to zero, and the baby should be undressed in clothes and diapers.
The baby's weight will be converted to WAZ.
The WAZ at the age of 6 months minus the WAZ converted from birth weight is the ΔWAZ at the age of 6 months after birth.
|
At the age of 6 months
|
|
ΔHAZ at 1 month of age compared to birth, separated into two groups.
Time Frame: At the age of 1 month
|
The baby's family has prepared a height measuring tool that is as precise as the ones used in hospitals.
The height measurement is within 0.1 centimeter accuracy.
The baby's height should be measured early in the morning on the day when the baby is 1 month old.
The baby's length will be converted into a HAZ.
The HAZ at the age of 1 month minus the HAZ converted from birth length is the ΔHAZ at the age of 1 month after birth.
|
At the age of 1 month
|
|
ΔHAZ at 3 months of age compared to birth, separated into two groups.
Time Frame: At the age of 3 months
|
The baby's family has prepared a height measurement tool that is as precise as those used in hospitals.
The height measurement is within 0.1 centimeter accuracy.
The baby's height should be measured early in the morning on the day the baby is 3 months old.
The baby's length will be converted into a HAZ.
The HAZ at the age of 3 months minus the HAZ converted from birth length is the ΔHAZ at the age of 3 months after birth.
|
At the age of 3 months
|
|
ΔHAZ at 6 months of age compared to birth, separated into two groups.
Time Frame: At the age of 6 months
|
The baby's family has prepared a height measurement tool that is as precise as those used in hospitals.
The height measurement is within 0.1 centimeter accuracy.
The baby's height should be measured early in the morning on the day the baby is 6 months old.
The baby's length will be converted into a HAZ.
The HAZ at the age of 6 months minus the HAZ converted from birth length is the ΔHAZ at the age of 6 months after birth.
|
At the age of 6 months
|
Collaborators and Investigators
Investigators
- Study Director: Ying Gu, Doctor, Children's Hospital of Fudan University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHFudan
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Defects, Congenital
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
Oslo University HospitalUniversity of BergenCompletedHeart Septal Defects, Atrial | Heart Defects,CongenitalNorway
-
Assiut UniversityNot yet recruitingCardiac Congenital Defects
-
Lifetech Scientific (Shenzhen) Co., Ltd.Chinese PLA General Hospital; Guangdong Provincial People's Hospital; Beijing... and other collaboratorsNot yet recruiting
-
China National Center for Cardiovascular DiseasesNot yet recruiting
-
SeptRx, Inc.UnknownHeart Septal Defects | Heart Defects, Congenital | Foramen Ovale, PatentGermany, France
-
Xinhua Hospital, Shanghai Jiao Tong University...RecruitingPostoperative Complications | Cardiac Catheterization | Congenital Heart Disease (CHD) | Ventricular Septal Defects (VSD)China
-
Medtronic Heart ValvesCompletedDysfunctional RVOT Conduits in Patients With Congenital Heart DefectsSpain, United States, Austria, Canada
-
Ain Shams UniversityCompletedHeart Defects, CongenitalEgypt
Clinical Trials on Conventional care
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
The Canadian College of Naturopathic MedicineUnknown
-
Zeng ChanghaoPeking University Sixth Hospital; Mianyang Central HospitalTerminatedNasopharyngeal Carcinoma | DysphagiaChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingGastrointestinal Stromal Tumors | Nursing CariesChina
-
University of the PhilippinesPfizerCompletedLow Birth Weight Among NeonatesPhilippines
-
Technische Universität DresdenNot yet recruitingIrreversible Loss of Brain Function (ILBF)Germany
-
Peking University Third HospitalRecruitingHyperlipidemia | Cardiometabolic DiseaseChina
-
Applied Physiology Pty LtdTrident Clinical Research Pty LtdCompletedCritical Illness | Intensive CareAustralia
-
National Cancer Institute, EgyptRecruiting
-
Yonsei UniversityRecruitingAdvanced Gastric CancerKorea, Republic of